Bibliographie - 2404 - Stabilis 4.0

Viimane versioon :
03/05/2024

Viited

Viited 2404

Tüüp :

Ajaleht

Interneti link :

http://pmj.sagepub.com/cgi/content/abstract/14/3/205

Uurimisrühmad :

Glasgow - University of Strathclyde, Department of Pharmaceutical Sciences

Autor :

Fielding H, Kyaterekera , Skellern GG, Tettey JN, McDade JR, ZMsuya Z, Watson DG, Urie J.

Pealkiri :

The compatibility and stability of octreotide acetate in the presence of diamorphine hydrochloride in polypropylene syringes

Publikatsioon :

Palliative Med ; 14: 205-208. 2000

Tõendite tase :

AideBibliographie

Füüsikaline stabiilsus :

Keemiline püsivus :

Muud meetodid :

Kommentaarid :

Ingredientide nimekiri

Süsteravim

Diamorphine hydrochloride

Analgeetikum

	6,25 mg/ml	+ Octreotide acetate	0,0375 mg/ml	+
	6,25 mg/ml	+ Octreotide acetate	0,1125 mg/ml	+
	6,25 mg/ml	+ Octreotide acetate	0,075 mg/ml	+
	12,5 mg/ml	+ Octreotide acetate	0,075 mg/ml	+
	12,5 mg/ml	+ Octreotide acetate	0,1125 mg/ml	+
	12,5 mg/ml	+ Octreotide acetate	0,0375 mg/ml	+
	25 mg/ml	+ Octreotide acetate	0,075 mg/ml	+

Süsteravim

Octreotide acetate

Mitmesugune

	0,0375 mg/ml	+ Diamorphine hydrochloride	6,25 mg/ml	+
	0,1125 mg/ml	+ Diamorphine hydrochloride	6,25 mg/ml	+
	0,075 mg/ml	+ Diamorphine hydrochloride	6,25 mg/ml	+
	0,075 mg/ml	+ Diamorphine hydrochloride	12,5 mg/ml	+
	0,1125 mg/ml	+ Diamorphine hydrochloride	12,5 mg/ml	+
	0,0375 mg/ml	+ Diamorphine hydrochloride	12,5 mg/ml	+
	0,075 mg/ml	+ Diamorphine hydrochloride	25 mg/ml	+

Mentions Légales